Nutex Health, Inc.NUTX

時価総額
$168.8億
PER
2011年
12月31日
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net income (loss)-383,393-1,623,895250,489-684,34283,809-7,432,241582,062----432,739,618
Depreciation and amortization--40,25063,250-----4,64813
Amortization of debt issuance costs----------50,354
Impairment of goodwill-111,026------3-398
Stock-based compensation expense------924,326450,05434189,581
Rescission of warrant exercise expense----------561,651
Deferred tax expense----------984,8105
Debt accretion expense----------2
(Gain) loss on lease termination--------25,174--
Non-cash lease expense----------64,143
Accounts receivable-------4,004-111,567-71,90074,880-56,622,133
Accounts receivable - related party-----------1,454,934
Inventories----------719,107
Prepaid expenses and other current assets267,596-74,428122,487-34,520-199,207119,96169,56445,28065,467161,1551
Accounts payable----------10
Accounts payable - related party-----------329,155
Accrued expenses and other current liabilities-----------1,311,865
Net cash from operating activities-659,136-518,687-183,151165,80544,907-274,223-714,623-4,040,578-1,475,075-6,703,53051
Acquisitions of property and equipment----------15
Cash acquired in reverse acquisition.----------13
Cash related to deconsolidation of Real Estates Entities----------2
Net cash from investing activities418,387417,7351,800-4,739--9,9902,050-748,196-60,9008-4,337,398
Proceeds from lines of credit----------3
Proceeds from notes payable----------815,881
Repayments of lines of credit----------72,055
Repayments of notes payable---------16,7657
Repayments of finance leases----------2
Recission of warrant exercise----------588,042
Proceeds from Warrant Exercises---------153,4244
Proceeds from Stock Options Exercised---------178,842644,974
Members' contributions----------5
Members' distributions----------51
Net cash from financing activities--19,127103,500-54,50051,277172,444711,5006497,47214-48,132,730
Net change in cash and cash equivalents---------15-1,863,020